Website stats for Replicel - replicel.com
Life-changing Cell Therapies Revolutionary Injectable Technology RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.
replicel.com was registered 1 decade 5 years ago. It has a alexa rank of #941,027 in the world. It is a domain having .com extension. It is estimated worth of $ 1,440.00 and have a daily income of around $ 6.00. As no active threats were reported recently, replicel.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 932 |
| Daily Pageviews: | 1,864 |
Estimated Valuation
| Income Per Day: | $ 6.00 |
| Estimated Worth: | $ 1,440.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 941,027 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
45 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
35.183.91.107
Hosted Country:
CA
Location Latitude:
45.5088Location Longitude:
-73.5878Traffic Classification
| Total Traffic: | Not Applicable |
| Direct Traffic: | Not Applicable |
| Referral Traffic: | Not Applicable |
| Search Traffic: | Not Applicable |
| Social Traffic: | Not Applicable |
| Mail Traffic: | Not Applicable |
| Display Traffic: | Not Applicable |
Search Engine Results For replicel.com
RepliCel Life Sciences Inc. - Home | Facebook
RepliCel is a regenerative medicine company focused on developing autologous cell therapies that address diseases caused by a deficit of healthy cells ...
RepliCel Announces Dermal Injector Update | BioSpace
Oct 27, 2021 ... RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the ...
RepliCel Life Sciences - Crunchbase Company Profile & Funding
RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.
RepliCel Files Notice of Arbitration against Shiseido Company to ...
Oct 18, 2021 ... RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the ...
RepliCel Life Sciences Inc. Profile - SEDAR
Business e-mail address: [email protected], Short Form Prospectus Issuer: Yes. Telephone Number: 604 248-8730, Reporting Jurisdictions: British Columbia, ...
Replicel.com | RCH-01 Technology Video - YouTube
View corporate snapshot here: http://www.replicel.com/investors/rep... RepliCel Life Sciences is developing an autologous cell-based ...
RepliCel - Wikipedia
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. ... The company focuses on development of cell therapies ...
RP.V - RepliCel Life Sciences Inc Profile | Reuters
Replicel Life Sciences Inc is a Canada-based regenerative medicine company. It develops autologous cell therapies that treat functional cellular deficits.
RepliCel Announces a Binding Term Sheet For Strategic
Nov 10, 2020 ... RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the ...
Replicel Life Sciences Inc REPCF:OTCPK - CNBC
Get Replicel Life Sciences Inc (REPCF:OTCPK) real-time stock quotes, news, price and financial information from CNBC.
RepliCel
RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for ...
Cell Therapy Is “Hair Raising” in a Good Way - Mary Ann Liebert, Inc.
Jun 16, 2020 ... The regenerative medicine company RepliCel Life Sciences is developing potential cures for chronic tendinosis, damaged or aging skin, ...
RepliCel Announces DermaPrecise Trademark for Dermal Injector ...
Oct 28, 2021 ... "RepliCel is very proud of the DermaPrecise injection product line which promises not only a high-level of electronic precision with control ...
REPCF | RepliCel Life Sciences Inc. Stock Overview (US - Barron's
Complete RepliCel Life Sciences Inc. stock information by Barron's. View real-time REPCF stock price and news, along with industry-best analysis.
RepliCel Provides Update on Shiseido License and Co ...
As announced in July, RepliCel's RCH-01 product, for the treatment of androgenetic alopecia, is now under clinical investigation at Tokyo Medical University ...
RepliCel Life Sciences Joins Centre for Commercialization ... - CCRM
- https://www.ccrm.ca/wp-content/uploads/2011/10/RepliCel-Joins-CCRM-Final.pdf
CCRM and RepliCel to Partner on Development of Cell Therapies for Tendon Repair. VANCOUVER, BC and Toronto, ON – September 3, 2014 – RepliCel Life Sciences ...
Replicel says hair loss therapy is safe, with glimmers of efficacy
Mar 14, 2017 ... A cell-based therapy for pattern baldness has passed its first phase 1 safety test. Now, developer Replicel Life Sciences says it is ...
RepliCel Life Sciences - Stock price, News & Analysis - Simply Wall St
Should you invest in RepliCel Life Sciences (OTCPK:REPC.F)? Weak fundamentals or lack of information. Last updated 2021/12/02 00:08.
Replicel Life Sciences Inc (RP-X) Quote - Press Release
May 25, 2021 ... Detailed price information for Replicel Life Sciences Inc (RP-X) from The Globe and Mail including charting and trades.
RepliCel Life Sciences Inc. Stock Quote (US - REPCF - MarketWatch
REPCF | Complete RepliCel Life Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Hair-raising R&D: RepliCel developing autologous cell therapy for ...
Jul 17, 2017 ... Vancouver, Canada-based RepliCel is developing an autologous cell therapy to treat patients with baldness due to androgenetic alopecia.
REPCF: RepliCel Life Sciences Inc Stock Price Quote - OTC US
Stock analysis for RepliCel Life Sciences Inc (REPCF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 2 | H2 Headings: | 2 |
| H3 Headings: | 7 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 14 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-131290504-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| look Your | 3 | 0.965 % | No |
| Your look | 3 | 0.965 % | No |
| RepliCel Life | 3 | 0.965 % | No |
| Your health | 3 | 0.965 % | No |
| health Our | 3 | 0.965 % | No |
| Life Sciences | 3 | 0.965 % | No |
| Press Release | 2 | 0.643 % | No |
| days ago | 2 | 0.643 % | No |
| is a | 2 | 0.643 % | No |
| ago Nov | 2 | 0.643 % | No |
| Our Science | 2 | 0.643 % | No |
| Skin Rejuvenation | 2 | 0.643 % | No |
| Release RepliCel | 2 | 0.643 % | No |
| About Contact | 2 | 0.643 % | No |
| Clinical Study | 2 | 0.643 % | No |
| For Partners | 2 | 0.643 % | No |
| Dermal Injector | 2 | 0.643 % | No |
| Technology Better | 2 | 0.643 % | No |
| For Patients | 2 | 0.643 % | No |
| For Investors | 2 | 0.643 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| look Your health Our | 3 | 0.965 % | No |
| Your look Your health | 3 | 0.965 % | No |
| Your health Our Science | 2 | 0.643 % | No |
| Oct 28 2021 Trademark | 1 | 0.322 % | No |
| ago Oct 28 2021 | 1 | 0.322 % | No |
| month ago Oct 28 | 1 | 0.322 % | No |
| 28 2021 Trademark registrations | 1 | 0.322 % | No |
| 1 month ago Oct | 1 | 0.322 % | No |
| Trademark registrations kickoff precommercial | 1 | 0.322 % | No |
| 2021 Trademark registrations kickoff | 1 | 0.322 % | No |
| registrations kickoff precommercial planningVANCOUVER | 1 | 0.322 % | No |
| Line 1 month ago | 1 | 0.322 % | No |
| DermaPrecise Trademark for Dermal | 1 | 0.322 % | No |
| Announces DermaPrecise Trademark for | 1 | 0.322 % | No |
| RepliCel Announces DermaPrecise Trademark | 1 | 0.322 % | No |
| Trademark for Dermal Injector | 1 | 0.322 % | No |
| for Dermal Injector Product | 1 | 0.322 % | No |
| Product Line 1 month | 1 | 0.322 % | No |
| Injector Product Line 1 | 1 | 0.322 % | No |
| Dermal Injector Product Line | 1 | 0.322 % | No |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
Websites Hosted on Same IP (i.e. 35.183.91.107)
Aspect Biosystems
We combine the power of microfluidics and 3D bioprinting to create living, human tissues that will save lives and make people healthier.
1,489,116 
$ 960.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Transfer-Encoding: chunked
Server: Microsoft-IIS/10.0
Access-Control-Allow-Credentials: true
Access-Control-Allow-Headers: Origin, X-Requested-With, Content-Type, Accept, Set-Cookie, withCredentials, Authorization
Access-Control-Allow-Origin:
Date: Sat, 04 Dec 2021 21:21:45 GMT
Domain Information
| Domain Registrar: |
Tucows Domains Inc.
|
|---|---|
| Registration Date: | 2009-04-24 1 decade 5 years 2 months ago |
| Last Modified: | 2021-03-16 3 years 3 months 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.unimaxx.com | |
207.194.216.8 | Canada |
| ns2.unimaxx.com | |
154.5.197.116 | Canada |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| replicel.com | A | 293 |
IP: 35.183.91.107 |
| replicel.com | NS | 86400 |
Target: ns2.unimaxx.com |
| replicel.com | NS | 86400 |
Target: ns1.unimaxx.com |
| replicel.com | SOA | 86400 |
MNAME: ns1.unimaxx.com RNAME: info.unimaxx.com Serial: 2021120400 Refresh: 86400 Retry: 7200 Expire: 3600000 |
| replicel.com | MX | 300 |
Priority: 5 Target: mailgateway1.unimaxx.com |
| replicel.com | TXT | 300 |
TXT: v=spf1 +a +mx +ip4:209.205.93.0/24 +ip4:207.194.216.0/24 +ip4:34.217.169.117 +ip4:52.26.163.228 ~all |
Alexa Traffic Rank
Alexa Search Engine Traffic
Full WHOIS Lookup
Registry Domain ID:
1553271249_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.tucows.com
Registrar URL: http://www.tucows.com
Updated
Date: 2021-03-15T21:41:03Z
Creation Date:
2009-04-23T20:08:49Z
Registry Expiry Date:
2022-04-23T20:08:49Z
Registrar: Tucows Domains Inc.
Registrar
IANA ID: 69
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.4165350123
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS1.UNIMAXX.COM
Name Server: NS2.UNIMAXX.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-12-04T08:37:35Z
Similarly Ranked Websites
RB Sellars | Casual, Corporate & Workwear For The Whole Family
Australian Family owned Clothing Brand. Specialising in Workwear and Casual Clothing for Australian families. Shop online with RB Sellars today.
941,028 $ 1,440.00
Nonprofit Marketing Agency - Media Cause
Media Cause is a full-service nonprofit marketing agency that helps organizations grow their reach and accelerate their impact.
941,034 $ 1,440.00
Concesiones Integrales - Concesiones Integrales - Inicio
Concesiones Integrales - Servicios de agua potable, drenaje, alcantarillado, saneamiento y disposición de aguas residuales en el Municipio de Puebla.
941,036 $ 1,440.00
Hardscape & Outdoor Living Space Designs from System Pavers
From driveway pavers to walkways, patios to pergolas, BBQ islands to Pool decks, System Pavers can design and build your beautiful outdoor living space.
941,037 $ 1,440.00